The Net Margin of Sprint Bioscience AB (SPRINT.ST) is 54.88%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2025-12-31 | 54.88% |
| 2024-12-31 | -27.84% |
| 2023-12-31 | -0.87% |
| 2022-12-31 | -72493.98% |
| 2021-12-31 | -71.43% |
| 2020-12-31 | -253.43% |
| 2019-12-31 | -64.21% |
| 2018-12-31 | -177.82% |
| 2017-12-31 | -44.49% |
| 2016-12-31 | 12.98% |